Navigation Links
Does Your Business Have the Tools to Compete in the World's Largest Diagnostics Markets?
Date:10/30/2013

MOUNTAIN VIEW, Calif., Oct. 30, 2013 /PRNewswire/ -- The inclusive and increasingly competitive in vitro diagnostics (IVD) landscape is evolving in unison with healthcare reform. Therefore, it is vital for all market participants to understand the transformation and manage amidst the changes.  Those even remotely invested in the market require crucial insight on business strategy and regulatory and technological advancements essential for success, in addition to current and future growth trends and market opportunities that will keep them a key player.

"Global IVD companies have been forced to adjust to a lower healthcare spending baseline for what is currently the world's largest IVD market, the United States," said Frost & Sullivan Life Sciences Senior Industry Analyst Winny Tan. "We used to describe the diagnostics market as highly cost-sensitive; now it is the entire healthcare industry that is cost-constrained. Competing in this business environment means growth strategies need to deliver the greatest value with low upfront investments. Potential strategies that fit a cost-constrained industry include identifying underpenetrated markets, leveraging external innovation partners and taking advantage of existing data."

To evaluate these strategies, Tan participates in IVD Business Strategy Conference (http://www.ivdtconference.com/), taking place Nov. 6-8, 2013, in San Diego, Calif.  Her presentation, "Evaluating Diagnostic Industry Growth Trends and Market Opportunities in Global Markets," is on day one of the event and will provide a competitive overview through an analysis of the global IVD market; an evaluation of market revenue opportunities, segment sizes and growth rates; and an assessment of emerging IVD markets.

IVD Business Strategy Conference 2013 provides a full scope view of the business strategy, regulatory and technology advancements essential to generating success in the IVD marketplace.  The event will feature real world case studies by providers as well as a half-day supplemental workshop on reimbursement strategies facilitated by Emerson Consulting.

This all-inclusive two-day conference program covers a range of topics to develop and successfully commercialize in vitro diagnostics, including what's to come for the IVD business landscape and identifying domestic and global growth trends and opportunities; pinpointing regulatory submission requirements for the U.S., Europe, and emerging markets and determining the best documentation approach for speed to market; applying the latest technology in sequencing, molecular diagnostics, wireless, and point of care devices to enhance your IVD product portfolio; and tackling challenges in regulatory approval, pricing, co-development, and relationship management when developing a companion diagnostic.

The conference is suited for IVD manufacturers looking for key regulatory, business and technical updates, as well as pharmaceutical companies looking to enter the personalized medicine arena. All top-level professionals from the following functions will benefit: companion diagnostics, personalized medicine, research and development, business development, manufacturing, regulatory affairs, innovation, pipeline/portfolio, and planning and project management.

The partnership with IVD Business Strategy Conference is part of Frost & Sullivan's Life Sciences Growth Partnership Service program.  Connect with us on social media, including Twitter, Facebook, SlideShare, and LinkedIn, for the latest news and updates.

About MD+DI
Medical Device + Diagnostic Industry (MD+DI) is a magazine and information resource exclusively for original equipment manufacturers of medical devices and in vitro diagnostic products. For more than 30 years, MD+DI has been the leading industry source of in-depth news and information to help industry professionals develop, design and manufacture medical products that comply with complex and demanding regulations and market requirements. Please visit www.mddionline.com for more information.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:
Jennifer Carson
Corporate Communications – North America
P: 210.247.2450
F: 210.348.1003
E: jennifer.carson@frost.com
Twitter: @Frost_Sullivan
Facebook: Frost & Sullivan

http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Turkey Businessman, Two Years Without a Human Heart, Goes Four-Wheeling
2. Anti-Adhesion Products - Global Strategic Business Report
3. Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
4. Dental Restorative Supplies - Global Strategic Business Report - 2013-2018
5. University of Miami Program To Train Health Care Executives on Tackling Ethical and Compliance Issues When Doing Business in Latin America
6. Medbox CEO Featured on FOX Business Network
7. GlySure Wins 2013 Small Business of the Year and New Product of the Year
8. Dental Prosthetic Supplies - Global Strategic Business Report 2013-2018 - Aging Global Population is a Major Growth Propeller
9. Indivumed Sells Inostics, the plasma-DNA Company, to Sysmex and Expands its Clinical Research Service and Patient Diagnostics Business
10. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
11. Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... 18, 2017  Astute Medical, Inc., developer of biomarkers ... be presented at the 2017 National Kidney Foundation (NKF) ... continues through April 22. Physicians will present data on ... assess risk for acute kidney injury (AKI) during the ... Elevated levels of TIMP-2 and IGFBP-7 ...
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext ... of collaboration started in 2016, in which Socionext ... Brain SOINN". The companies achieved initial results in ... solution by Artificial Brain SOINN. The results will ... Big Sight, April 19-21, at booths 4505 & ...
(Date:4/18/2017)... April 18, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... of bacterial infections, will present preclinical data supporting the ... multidrug resistant (MDR) Gram-negative infections at the 27th European ... 22-25, 2017 in Vienna, Austria . ... "Our ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the Renaissance ... program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish we ... entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. Ted ...
(Date:4/24/2017)... Calif. (PRWEB) , ... April 24, 2017 , ... Donna ... topics, but she has not found any of them to be very practical. She ... to slowly and easily make changes in their health. It prompted her in writing ...
(Date:4/24/2017)... ... 2017 , ... “Reflections of God’s Work”: an enlightening collection of life lessons ... creation of published author, Jerri Broglin, a survivor of great loss who gained insight ... great eye-opener for those searching for answers, as we are finding the answers that ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... , ... April 24, 2017 , ... Life of Purpose ... of Florida. The event will be held at 7:30 pm on May 10th at ... and Drew Copeland of Sister Hazel, will support the UF Collegiate Recovery Community (UFCRC). ...
Breaking Medicine News(10 mins):